On September 15, Nutra Ingredients quoted Claudia Lewis on ongoing litigation regarding supplements pertaining to weight management. According to the article, some professionals are seeing an influx of litigation pertaining to the efficacy and regulation of weight-loss supplements.
A recent instance of this concerns the wellness brand Lemme Inc. The company faced allegations of misleading marketing practices earlier this year. “[The Lemme] supplement is advertised to work by increasing the amount of GLP-1 in the body,” said Lewis. “However, the plaintiff alleges that merely increasing the amount of GLP-1 in the body does not help achieve weight loss, because GLP-1 has such a short half-life at only about two minutes.”
She also referenced that some litigation alleges that “weight loss supplements are ‘unapproved new drugs’ because of express or implied references to the treatment or prevention of obesity.”
Click here to access the article.